Epidemiology
A subtype of rhabdomyosarcoma that can affect children or adults and present in the soft tissues of the limbs. The molecular subtype matters because some alterations are associated with more aggressive behavior than the name alone suggests.
Basic features
It shows spindle-shaped cells or a sclerosing (dense fibrous) stroma; molecular tests such as MYOD1 can change the risk assessment.
Usual treatment
It requires multimodal management with chemotherapy, surgery, and radiotherapy, depending on age, site, extent, and molecular biology. Before chemotherapy starts it is worth discussing fertility preservation with the team, because some of these treatments can affect it and the options have to be raised beforehand.
Outcomes and prognosis
The prognosis is variable and depends on age, resectability, metastasis, and genetic alterations.
